342 related articles for article (PubMed ID: 7520594)
1. [Percutaneous treatment of hilar cholangiocarcinoma completed by high-dose rate brachytherapy. Experience in the first 5 cases].
Righi D; Maass J; Zanon E; Tettoni S; Orecchia R; Lazzari R; Ragona R; Gandini G
Radiol Med; 1994; 88(1-2):79-85. PubMed ID: 7520594
[TBL] [Abstract][Full Text] [Related]
2. A novel endoscopic approach to brachytherapy in the management of Hilar cholangiocarcinoma.
Simmons DT; Baron TH; Petersen BT; Gostout CJ; Haddock MG; Gores GJ; Yeakel PD; Topazian MD; Levy MJ
Am J Gastroenterol; 2006 Aug; 101(8):1792-6. PubMed ID: 16780552
[TBL] [Abstract][Full Text] [Related]
3. Endoscopically inserted nasobiliary catheters for high dose-rate brachytherapy as part of neoadjuvant therapy for perihilar cholangiocarcinoma.
Mukewar S; Gupta A; Baron TH; Gores G; Furutani K; Haddock MG; Hallemeier CL
Endoscopy; 2015 Oct; 47(10):878-83. PubMed ID: 25961442
[TBL] [Abstract][Full Text] [Related]
4. [Unresectable hilar cholangiocarcinoma: combined percutaneous and radiotherapic treatment].
Golfieri R; Giampalma E; Muzzi C; Maffei M; Amore B; Grazia C; Frezza G; Galuppi A; Gavelli G
Radiol Med; 2001 Jun; 101(6):495-502. PubMed ID: 11479448
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
Isayama H; Tsujino T; Nakai Y; Sasaki T; Nakagawa K; Yamashita H; Aoki T; Koike K
World J Gastroenterol; 2012 May; 18(19):2364-70. PubMed ID: 22654427
[TBL] [Abstract][Full Text] [Related]
6. [Palliative locoregional therapy for hilar cholangiocarcinoma: photodynamic therapy and brachytherapy].
Dumoulin FL; Horst E; Sauerbruch T; Gerhardt T
Zentralbl Chir; 2007 Aug; 132(4):336-41. PubMed ID: 17724637
[TBL] [Abstract][Full Text] [Related]
7. Placement of ¹²⁵I seed strands and stents for a type IV Klatskin tumor.
Zhang W; Yang ZQ; Shi HB; Liu S; Zhou WZ; Zhao LB
World J Gastroenterol; 2015 Jan; 21(1):373-6. PubMed ID: 25574114
[TBL] [Abstract][Full Text] [Related]
8. Unresectable hilar cholangiocarcinoma: multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy.
Golfieri R; Giampalma E; Renzulli M; Galuppi A; Vicenzi L; Galaverni MC; Cappelli A
In Vivo; 2006; 20(6A):757-60. PubMed ID: 17203762
[TBL] [Abstract][Full Text] [Related]
9. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy.
Kuvshinoff BW; Armstrong JG; Fong Y; Schupak K; Getradjman G; Heffernan N; Blumgart LH
Br J Surg; 1995 Nov; 82(11):1522-5. PubMed ID: 8535808
[TBL] [Abstract][Full Text] [Related]
10. Cholangiocarcinoma: the impact of tumor location and treatment strategy on outcome.
Heron DE; Stein DE; Eschelman DJ; Topham AK; Waterman FM; Rosato EL; Alden M; Anne PR
Am J Clin Oncol; 2003 Aug; 26(4):422-8. PubMed ID: 12902899
[TBL] [Abstract][Full Text] [Related]
11. Malignant biliary duct obstruction: long-term experience with Gianturco stents and combined-modality radiation therapy.
Eschelman DJ; Shapiro MJ; Bonn J; Sullivan KL; Alden ME; Hovsepian DM; Gardiner GA
Radiology; 1996 Sep; 200(3):717-24. PubMed ID: 8756921
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic irradiation and parallel arrangement of Wallstents for hilar cholangiocarcinoma.
Kubota Y; Takaoka M; Kin H; Ogura M; Yamamoto S; Tsuji K; Yanagitani K; Inoue K
Hepatogastroenterology; 1998; 45(20):415-9. PubMed ID: 9638416
[TBL] [Abstract][Full Text] [Related]
13. Intraluminal brachytherapy with metallic stenting in the palliative treatment of malignant obstruction of the bile duct.
Kocak Z; Ozkan H; Adli M; Garipagaoglu M; Kurtman C; Cakmak A
Radiat Med; 2005 May; 23(3):200-7. PubMed ID: 15940068
[TBL] [Abstract][Full Text] [Related]
14. Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.
Válek V; Kysela P; Kala Z; Kiss I; Tomásek J; Petera J
Eur J Radiol; 2007 May; 62(2):175-9. PubMed ID: 17344008
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
[TBL] [Abstract][Full Text] [Related]
16. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach.
Paik WH; Park YS; Hwang JH; Lee SH; Yoon CJ; Kang SG; Lee JK; Ryu JK; Kim YT; Yoon YB
Gastrointest Endosc; 2009 Jan; 69(1):55-62. PubMed ID: 18657806
[TBL] [Abstract][Full Text] [Related]
17. Unresectable perihilar cholangiocarcinoma: multimodal palliative treatment.
Mosconi C; Renzulli M; Giampalma E; Galuppi A; Balacchi C; Brandi G; Ercolani G; Bianchi G; Golfieri R
Anticancer Res; 2013 Jun; 33(6):2747-53. PubMed ID: 23749936
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Metallic Stent Placement for Palliative Management of Malignant Biliary Hilar Obstruction.
Shim DJ; Gwon DI; Han K; Kim Y; Ko GY; Shin JH; Ko HK; Kim JH; Kim JW; Yoon HK; Sung KB
Korean J Radiol; 2018; 19(4):597-605. PubMed ID: 29962866
[TBL] [Abstract][Full Text] [Related]
19. [Percutaneous self-expanding metallic endoprosthesis and malignant biliary stenoses].
d'Alincourt A; Lerat F; Gibaud H; Paineau J; Leborgne J; Visset J
J Radiol; 1998 Jan; 79(1):39-43. PubMed ID: 9757219
[TBL] [Abstract][Full Text] [Related]
20. Unresectable hilar cholangiocarcinoma: multimodality treatment with percutaneous and intraluminal plus external radiotherapy.
Golfieri R; Giampalma E; Fusco F; Galuppi A; Faccioli L; Galaverni C; Frezza G
J Chemother; 2004 Nov; 16 Suppl 5():55-7. PubMed ID: 15675480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
